Drs Cerulli, Feld, Cutler, Mao, and Amann discuss prevalence and presentation of ADHD in pediatric, adolescent and adult populations.

ADHD experts discuss presentation and underdiagnosis of ADHD in adults.

Panelists share clinical burden of ADHD and how it impacts pediatric, adolescent and adult populations.

Psychiatrists share how they have incorporated telemedicine in the management of ADHD in their clinics.

ADHD experts discuss their approaches to management of ADHD in patients with comorbidities.

Drs Cerulli and Cutler discuss factors guiding treatment selection in ADHD.

Dr Amann and other experts discuss importance of carefully weighing patient and parent expectations and goals when choosing treatment.

Dr Cutler shares treatment options for ADHD.

Dr Feld highlights several formulations that are available to treat ADHD.

Psychiatrists share their approach to choosing between different ADHD medications and formulations.

Panelists discuss the importance of choosing treatments that are individualized to their patients.

Birgit H. Amann, MD, PLLC, discusses 2 recently approved treatment options for ADHD: amphetamine XR oral tablets and viloxazine.

Panelists discuss the use of amphetamine XR oral tablets in their practice and for which patients they’re using them.

Drs Cerulli and Cutler discuss the data and pharmacological properties of amphetamine XR oral tablets.

ADHD experts discuss novel treatments and unmet needs in pediatric and adult patients.

ADHD experts discuss strategies for improving access to ADHD medications for their patients.

Drs Feld, Cutler, Mao, and Amann discuss unmet needs in the management of ADHD.

ADHD experts share their final thoughts on the treatment and management of ADHD.